Post-exposure prophylaxis (PEP)
Showing 1 - 25 of >10,000
Post-exposure Prophylaxis, Sexually Transmitted Diseases, Doxycycline Trial (Samples)
Not yet recruiting
- Post-exposure Prophylaxis
- +2 more
- Samples
- (no location specified)
Aug 21, 2023
Rabies Post-exposure Prophylaxis Trial in Kunming (GR1801, Human Rabies Immunoglobulin(HRIG), Rabies Vaccine)
Recruiting
- Rabies Post-exposure Prophylaxis
- GR1801
- +2 more
-
Kunming, Yunnan, ChinaCenter for Disease Control and Prevention (CDC)
May 3, 2023
HIV Trial in Boston (TRUVADA + raltegravir)
Completed
- HIV Infections
- TRUVADA + Raltegravir
-
Boston, MassachusettsFenway Community Health
Oct 4, 2022
Leprosy Trial in Moroni (BE-PEP Bedaquiline, SDR-PEP Rifampicin, BE-PEP Rifampicin)
Not yet recruiting
- Leprosy
- BE-PEP Bedaquiline
- +2 more
-
Moroni, ComorosFondation Damien
Oct 24, 2022
Leprosy Trial in Gege (BE-PEP (Bedaquiline), SDR-PEP, BE-PEP (Rifampicine))
Recruiting
- Leprosy
- BE-PEP (Bedaquiline)
- +2 more
-
Gege, Anjouan, ComorosFondation Damien
Sep 20, 2022
Sexually Transmitted Diseases Trial in Atlanta (Doxycycline, Biktarvy)
Completed
- Sexually Transmitted Diseases
-
Atlanta, GeorgiaHope Clinic
Sep 20, 2022
SARS-CoV-2 Infection Trial in Beijing (HH-120 nasal spray 1, HH-120 nasal spray 2, Placebo Comparator 1)
Completed
- SARS-CoV-2 Infection
- HH-120 nasal spray 1
- +3 more
-
Beijing, Beijing, ChinaBeijing Ditan Hospital,Capital Medical University
Mar 1, 2023
COVID-19, Corona Virus Infection, SARS (Severe Acute Respiratory Syndrome) Trial in United States (Hydroxychloroquine Sulfate,
Completed
- COVID-19
- +3 more
- Hydroxychloroquine Sulfate
- Ascorbic Acid
-
Los Angeles, California
- +7 more
Dec 14, 2021
Covid19, COVID-19 Prevention Trial in Chandigarh (Hydroxychloroquine (HCQ), Standard care, Placebo)
Recruiting
- Covid19
- COVID-19 Prevention
- Hydroxychloroquine (HCQ)
- +2 more
-
Chandigarh, IndiaPost Graduate Institute of Medical Education and Research
Jun 8, 2021
HIV, HIV/AIDS, Neisseria Gonorrheae Infection Trial in Kisumu (Doxycycline)
Active, not recruiting
- HIV Infections
- +4 more
-
Kisumu, KenyaKenya Medical Research Institute
Feb 21, 2022
2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease Trial in United States (Famotidine,
Terminated
- 2019 Novel Coronavirus Disease
- +11 more
- Famotidine
- +2 more
-
Newport Beach, California
- +14 more
Jul 20, 2022
Respiratory Viral Infections, in Particular SARS-CoV-2, for Prevention of Onward Transmission, Respiratory Tract Diseases Trial
Recruiting
- Respiratory Viral Infections, in Particular SARS-CoV-2, for Prevention of Onward Transmission
- Respiratory Tract Diseases
- RESP301, a Nitric Oxide generating solution
-
London, United KingdomImperial College Healthcare NHS Trust
Apr 12, 2021
Subjects Receiving Rabies Post-exposure Prophylaxis in Cambodia
Completed
- Rabies Post-exposure Prophylaxis
- Intramuscular (IM) rabies post-exposure prophylaxis
- Intradermal (ID) rabies post-exposure prophylaxis
-
Phnom Penh, CambodiaInstitut Pasteur du Cambodge (IPC)
Jan 11, 2023
Hiv Trial (decision aid)
Not yet recruiting
- Hiv
- decision aid
- (no location specified)
Nov 17, 2023
Healthy Volunteers (Rabies Immunization) Trial in Cebu City, Muntinlupa (HDCV, PVRV)
Completed
- Healthy Volunteers (Rabies Immunization)
- HDCV
- PVRV
-
Cebu City, Philippines
- +1 more
Apr 22, 2022
COVID-19, Corona Virus Infection Trial in New York (Hydroxychloroquine, Placebo oral tablet)
Recruiting
- COVID-19
- Corona Virus Infection
- Hydroxychloroquine
- Placebo oral tablet
-
New York, New YorkColumbia University Irving Medical Center
Apr 23, 2020
COVID-19 Trial (IBIO123, Placebo)
Not yet recruiting
- COVID-19
- IBIO123
- Placebo
- (no location specified)
Dec 5, 2022
Monkeypox Trial in Nigeria (Bavarian Nordic smallpox vaccine, Typhoid VI Polysaccharide Vaccine Injectable Solution)
Not yet recruiting
- Monkeypox
- Bavarian Nordic smallpox vaccine
- Typhoid VI Polysaccharide Vaccine Injectable Solution
-
Abuja, Nigeria
- +7 more
Feb 16, 2023